6 women’s health developments in 2026 you need to know
From heart health to menopause, endometriosis to chronic pain, the medical spotlight is turning to women - and it’s about time!
For decades, women have been told that their symptoms were normal: pain was “just part of being a woman”, exhaustion was stress, and brain fog was expected in ageing.
In 2026, that narrative is beginning to change, and it can’t come soon enough.
Across healthcare, research, policy and public conversation, one theme has emerged again and again: women’s health is finally being recognised as more than reproductive health.
From endometriosis and menopause to heart disease, chronic pain and neurodiversity, researchers are questioning decades of assumptions that were built largely around male bodies and male experiences. The result is one of the most significant shifts in women’s healthcare in a generation. Here are six of the top stories from this year so far…
Menopause is finally being treated as a serious health transition
In 2026, researchers are increasingly treating menopause as a major biological transition with implications across the entire body.
New research suggests cardiovascular health may begin to decline during perimenopause, before menopause itself occurs. Changes in cholesterol levels and blood sugar regulation appear earlier than previously understood, raising important questions about whether women should be screened sooner for heart disease risk.
At the same time, menopause is becoming a neurological conversation. Research from University of Cambridge has linked menopause to changes in brain structure, sleep disruption, anxiety and cognitive symptoms. The significance is not that menopause damages the brain, but that symptoms often dismissed as “just stress” may have a genuine biological basis.
For millions of women who have struggled with concentration, memory lapses and so-called “brain fog”, that shift in understanding is significant.
Validation matters. So does research.
New Endometriosis research to help millions
Despite affecting millions of women worldwide, diagnosis in the UK still takes an average of more than nine years. Yet 2026 has delivered some of the most hopeful developments in endometriosis research for decades.
Researchers are increasingly treating endometriosis as a complex inflammatory disease that can affect the whole body, rather than simply a menstrual disorder. This broader understanding may ultimately transform treatment approaches and improve outcomes for the one in ten women and girls of reproductive age worldwide - an estimated 190 million people - who live with endo.
Even more promising are advances in diagnostics.
One of the most exciting developments is coming from Oxford University, where researchers are trialling a non-invasive imaging technique designed to identify endometriosis tissue without surgery. Early pilot results suggest the scan could detect disease with far greater accuracy than existing procedures. If larger studies confirm the findings, it could dramatically reduce the need for diagnostic laparoscopy and shorten the years-long journey many women face before receiving answers.
Earlier diagnosis would not only reduce suffering but could also improve fertility outcomes, treatment options and long-term quality of life.
Funding focus on women’s heart health
Heart disease remains one of the leading causes of death among women globally. Yet for decades, cardiovascular medicine has largely been shaped by research conducted in men.
The consequences have been significant. Women often experience different symptoms during heart attacks, including fatigue, nausea, breathlessness, jaw pain and upper-back discomfort rather than the “classic” chest pain that many people associate with cardiac events. Those differences have contributed to missed diagnoses and delayed treatment.
This year, researchers have increasingly focused on menopause, hormones and sex-specific cardiovascular risk factors. In one of the largest investments in women’s cardiovascular research to date, the VISIBLE initiative from Wellcome Leap - jointly funded by Pivotal - announced $55 million in funding dedicated to improving understanding of women’s heart health. The programme aims to accelerate research into how heart disease develops differently in women and to improve prevention, diagnosis and treatment strategies that have historically been based on male-centred data.
The investment reflects a growing recognition that closing the women’s health gap is not only a medical challenge but an economic and societal one.
Neurodiversity is forcing a rethink of women’s health
Another area undergoing rapid change is the understanding of ADHD and autism in women.
Historically, diagnostic criteria were based largely on male presentations. As a result, countless women have reached adulthood before receiving diagnoses, often after years of struggling with anxiety, depression, burnout or other challenges that masked the underlying condition. New research this year states: “Gender bias and frequent misdiagnosis were recurrent issues, contributing to significant psychological distress. The findings emphasise the urgent need for gender-sensitive diagnostic frameworks, enhanced professional training, and a person-centred approach to care.”
Researchers are increasingly exploring how ADHD and autism present differently in women, including the role of masking behaviours and hormonal fluctuations.
Recently studies have shown “Autistic people and ADHDers may be particularly vulnerable to difficulties during menopause”. Doctors have found women seek assessment during perimenopause, when hormonal changes can disrupt coping strategies that previously helped them navigate daily life.
The result is a growing recognition that female neurodiversity deserves female-specific research.
Women’s Health Research Heads to Space
One of the most unexpected women’s health stories of the year is not happening in a hospital or research laboratory, but in orbit.
In 2027, the world’s first space mission dedicated to menstrual health research is scheduled to launch, marking a significant milestone in understanding how female biology responds to extreme environments.
Despite more than six decades of human spaceflight, little research has been conducted on menstruation and reproductive health in space. Scientists hope the mission will provide valuable insights into hormonal regulation, reproductive function and long-term health impacts in conditions of microgravity. The research has the potential to deepen our understanding of menstrual health, hormonal changes and women’s physiology more broadly.
For generations, women were excluded from medical research because their bodies were considered too complex to study. Now, researchers are preparing to investigate women’s health beyond the boundaries of Earth itself.
Melinda French Gates donates $215 million to women’s health
Philanthropist Melinda French Gates has announced an additional $215 million donation towards women’s health, with a new focus on menopause. Currently, less than 1% of aging research focuses on menopause. The additional funding brings her total investment into women’s health issues to more than $600 million in two years.
Related articles
“Women deserve to live in a world that prioritizes their health—full stop. I’m continuing my focus on reproductive and maternal health—protecting contraceptive access, strengthening community-based maternal care, and integrating mental health support into routine care. I’m also turning more attention to midlife—supporting new research on conditions impacting women’s lives and improving care for menopause and perimenopause. It’s time to make women’s health a priority—because when women are healthier, everyone benefits. That’s the future we should be building,” she wrote recently.
Melinda founded Pivotal, a group of organisations working to accelerate the pace of social progress for women and young people in USA. and around the world, in 2015 and continues to invest in research to improve the everyday lives of women.
This is what true altruism looks like.
What happens next?
Women’s health is receiving more attention than ever before. Researchers are asking better questions. Governments are acknowledging longstanding failures. New diagnostic tools and treatments are emerging.
Yet many women still face long waiting lists, delayed diagnoses and inconsistent access to care.
The healthcare system is moving forward for women. The question is whether it can move fast enough.
The new endo research is exciting! Curious to read about the space study once it's live
Such an important read, and huge steps in the right direction towards improving womens health! P.S. Nice one, Mel!